# An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib

> **NCT01932229** · PHASE2 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 20 (estimated)

## Conditions studied

- NSCLC

## Interventions

- **DRUG:** Afatinib treatment

## Key facts

- **NCT ID:** NCT01932229
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-02
- **Primary completion:** 2015-01
- **Final completion:** —
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2013-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01932229

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01932229, "An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01932229. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*